DXCM Stock Analysis: Dexcom Inc
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their dig
- Latest close
- $86.29
- 20-day change
- -4.27%
- Trend state
- NEUTRAL
- Classification
- Healthcare · Medical - Devices
Market context
Dexcom Inc moved -4.27% over the latest 20-session window. BullRecon currently classifies the broader setup as NEUTRAL.
Latest report
The latest cached company filing period (FY2025 · $4.7B revenue · $836.3M net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Quality is currently the strongest dimension at 5.6/6, while Value is the lowest at 3.7/6. Scores are comparative research signals, not forecasts.